TARS1
protein-codingthreonyl-tRNA synthetase 1, the group of Aminoacyl tRNA synthetases, Class II
Gene summary
Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Threonyl-tRNA synthetase belongs to the class-II aminoacyl-tRNA synthetase family [provided by RefSeq, Jul 2008]
- TARS
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~27.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0018053
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0032806
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0032806
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Dermatologic; Musculoskeletal; Neurologic
Intervention: Allergy/Immunology/Infectious
Rationale: The condition has been described as involve recurrent respiratory infections, and awareness may allow prompt diagnosis and management of infections
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TARS1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_152295.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 4 | 1 | 7 | ||
| missense | 2 | 120 | 3 | 6 | 131 | |
| nonsense | 1 | 1 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 2 | 1 | 3 | |||
| splice donor/acceptor (+/-2bp) | 12 | 12 | ||||
| Total | 3 | 2 | 136 | 7 | 7 | 155 |
Highest pathogenic variant AF is 0.000016331782
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_689508.3 | 19 | MANE Select | |
| Ensembl | ENSP00000265112.3 | 19 | MANE Select | |
| RefSeq | NP_001245366.1 | 19 | Standard | |
| RefSeq | NP_001245367.1 | 20 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Aminoacyl-tRNA biosynthesis - Homo sapiens (human)
- tRNA Aminoacylation
- Translation
- Metabolism of proteins
- Glycine Serine metabolism
Biological Process
- translation
- tRNA aminoacylation for protein translation
- threonyl-tRNA aminoacylation
Molecular Function
- tRNA binding
- threonine-tRNA ligase activity
- protein binding
- ATP binding
- protein homodimerization activity
Cellular Component
- cytoplasm
- cytosol
- actin cytoskeleton
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000455217
- Coding exons
- 20
- Length
- 28843
- Individuals with no LoFs
- 125678
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 70
- Defined
- 125748
- p
- 0.000278
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.15 | 354 | 420 | 0.842 | 0.0000224 | 5006 |
| Missense (PolyPhen) | 118 | 159.62 | 0.73927 | 1855 | ||
| Synonymous | -0.316 | 148 | 143 | 1.03 | 0.00000756 | 1360 |
| Loss of Function | 2.67 | 27 | 46.7 | 0.578 | 0.00000251 | 540 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00046 | 0.00043 | rare |
| Latino/Admixed American | 0.00050 | 0.00049 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00076 | 0.00076 | rare |
| Finnish | 0.000093 | 0.000092 | rare |
| European (Non-Finnish) | 0.00022 | 0.00022 | rare |
| South Asian | 0.00017 | 0.00016 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.144
Intolerance Scores
- LoFtool
- 0.546
- RVIS EVS
- 0.6
- RVIS percentile EVS
- 82.87
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.957
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |